Friday - May 23, 2025
Some Patients May Experience Durable Disease Control Even After Discontinuing Immune Checkpoint Inhibitors for Side Effects
April 18, 2025
PHILADELPHIA, Pennsylvania, April 18 [Category: Medical] -- The American Association for Cancer Research posted the following news release:

* * *

Some Patients May Experience Durable Disease Control Even After Discontinuing Immune Checkpoint Inhibitors for Side Effects

PHILADELPHIA - A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due to immune-related adverse events (irAEs) continued t . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products